Dear all,

My apologies for the spam-like nature of my post, but I would like to draw your 
attention to an important issue (outlined in an upcoming short communication to 
Acta D, which will appear at doi:10.1107/S1399004715000826 once it's online). 
At present, neither the structural quality checks in commonly-used 
crystallography packages nor those run on deposition of a structure to the PDB 
are flagging the presence of non-proline cis peptide bonds. This has led to the 
presence of many erroneous cis bonds creeping into the PDB - primarily in 
low-resolution structures as one would expect, but I have identified clearly 
erroneous examples in structures with resolutions as high as 1.3 Angstroms. 
From my analysis, I estimate that a few thousand structures have been affected 
to some extent, with the worst cases having as high as 3% of their peptide 
bonds in cis. Particularly if you have published anything >2.5 Angstroms in the 
past few years, may I gently suggest that you make a quick double-check of your 
deposited structures? This can be done quickly and simply in Coot 
(Extensions-Modelling-Residues with Cis peptide bonds).


Best regards,


Tristan

Reply via email to